Central geographic atrophy vs. neovascular age–related macular degeneration: differences in longitudinal vision-related quality of life
- 19 August 2020
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 259 (2) , 307-316
Abstract
Objective Prior studies of vision-related quality of life (VRQoL) have examined advanced age-related macular degeneration (AMD) as a single group or focused on neovascular AMD (nAMD), even though advanced AMD can refer to either central geographic atrophy (GA) or nAMD. We compared the natural progression of VRQoL in central GA versus nAMD. Methods We included Age-Related Eye Disease Study (AREDS) participants with central GA (n = 206) or nAMD (n = 198) who completed the National Eye Institute Visual Function Questionnaire (NEI-VFQ) between 1997 and 2005. The rate of change of VRQoL was calculated as the slopes of linear models fit to longitudinal individual-level NEI-VFQ scores. Multivariable regressions identified factors associated with experiencing a decline in VRQoL during the study period and cross-sectional VRQoL score. Results There was a minor decline in VRQoL prior to the development of nAMD but a significantly steeper decline after progression to nAMD (0.49 ± 2.91 vs. 3.30 ± 5.58 NEI-VFQ units/year; p < 0.001). The rates of VRQoL decline were similar before and after the development of central GA (1.99 ± 4.97 vs. 1.68 ± 4.65 NEI-VFQ units/year; p = 0.66). Prior to the development of advanced AMD, the rate of VRQoL decline was greater for participants destined to develop central GA versus nAMD (p = 0.007), while postprogression to advanced disease, the rate was greater in nAMD compared with central GA (p = 0.012). Female gender (odds ratio [OR] 2.61, 95% confidence interval [CI] 1.38-5.06; p = 0.003) and higher baseline VRQoL score (OR 1.03, 95% CI 1.01–1.06; p = 0.006) were independently associated with experiencing a longitudinal decline in VRQoL. Conclusion The natural progression of VRQoL differed in central GA versus nAMD, both before and after the development of advanced disease, suggesting that future studies should consider separating these phenotypes. Females and those with a higher baseline VRQoL were more likely to experience a longitudinal decline in VRQoL following progression to advanced AMD.Keywords
Funding Information
- National Institute on Aging (T35AG049685)
- National Eye Institute (NEI P30EY026878)
This publication has 41 references indexed in Scilit:
- Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practiceClinical Ophthalmology, 2013
- Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2011
- Impact of Age-Related Macular Degeneration on Vision-Specific Quality of Life: Follow-up from the 10-Year and 15-Year Visits of The Study of Osteoporotic FracturesAmerican Journal of Ophthalmology, 2010
- Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2010
- The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) ProjectInvestigative Ophthalmology & Visual Science, 2008
- The Effectiveness of Low-Vision Rehabilitation on Participation in Daily Living and Quality of LifeInvestigative Ophthalmology & Visual Science, 2007
- Longitudinal Changes in Visual Acuity in KeratoconusInvestigative Ophthalmology & Visual Science, 2006
- Differences in Keratoconus as a Function of GenderAmerican Journal of Ophthalmology, 2005
- Vision-related quality of life in patients with bilateral severe age-related macular degenerationOphthalmology, 2005
- Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4American Journal of Ophthalmology, 2004